Skip to main content
. 2019 Dec 19;2019(12):CD009359. doi: 10.1002/14651858.CD009359.pub2

Comparison 1. Racecadotril versus placebo/no treatment.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Failure of rehydration 2 192 Risk Ratio (M‐H, Fixed, 95% CI) 0.41 [0.13, 1.23]
2 Number of stools within 24 hours 2 258 Mean Difference (IV, Fixed, 95% CI) ‐0.24 [‐0.90, 0.43]
3 Number of stools between 24 to 48 hours 2 258 Mean Difference (IV, Random, 95% CI) ‐0.80 [‐1.87, 0.27]
4 Stool output within 24h 1 167 Mean Difference (IV, Fixed, 95% CI) ‐5.5 [‐7.71, ‐3.29]
5 Stool output within 48h 2   Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1 Stool output within 48 hours (all patients) 2 301 Std. Mean Difference (IV, Fixed, 95% CI) ‐0.65 [‐0.88, ‐0.41]
5.2 Stool output within 48 hours (rotavirus‐positive patients) 2 128 Std. Mean Difference (IV, Fixed, 95% CI) ‐0.83 [‐1.19, ‐0.47]
6 Adverse events 5 688 Risk Ratio (M‐H, Random, 95% CI) 0.90 [0.66, 1.22]